HeartSciences (HSCS) Shares Outstanding (2021 - 2026)
HeartSciences' (HSCS) quarterly Shares Outstanding (Entity) came in at $2.6 million in Q2 2026, up 134.6% YoY from $1.1 million in Q2 2025, and up 134.6% on a QoQ basis from $1.1 million in Q4 2025.
HeartSciences (HSCS) Shares Outstanding (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has 6 years of Shares Outstanding (Entity) data on file, last reported at $2.6 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 134.6% year-over-year to $2.6 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $2.6 million (up 134.6% YoY) and the FY2026 annual result came in at $2.6 million, up 134.6% from the prior year.
- Shares Outstanding (Entity) rose to $2.6 million in Q2 2026, from $1.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $3.1 million in Q4 2025 to a low of $33239.0 in Q1 2022.
- A 5-year average of $761132.2 and a median of $494318.0 in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) jumped 36.57% — and 2024, when it soared 749.42%.
- Tracing HSCS's Shares Outstanding (Entity) over 5 years: stood at $82105.0 in 2022, then soared by 36.57% to $112134.0 in 2023, then jumped by 745.26% to $947821.0 in 2024, then climbed by 18.07% to $1.1 million in 2025, then jumped by 134.6% to $2.6 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $2.6 million (Q2 2026), $1.1 million (Q4 2025), and $3.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 97.60 Mn |
| 10 | HeartSciences | 6.64 Mn | 4.94 Mn | - | 2.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.63 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Oct 31, 2025 | 2.78 Mn |
| Jul 31, 2025 | 1.30 Mn |
| Apr 30, 2025 | 938,257.00 |
| Jan 31, 2025 | 986,057.00 |
| Oct 31, 2024 | 917,445.00 |
| Jul 31, 2024 | 777,746.00 |
| Apr 30, 2024 | 352,520.00 |
| Jan 31, 2024 | 537,927.00 |
| Oct 31, 2023 | 109,389.00 |
| Jul 31, 2023 | 103,315.00 |
| Apr 30, 2023 | 79,506.00 |
| Jan 31, 2023 | 82,408.00 |
| Oct 31, 2022 | 82,105.00 |
| Jul 31, 2022 | 56,452.00 |
| Apr 30, 2022 | 33,189.00 |
| Jan 31, 2022 | 33,235.00 |
| Oct 31, 2021 | 33,138.00 |
| Jul 31, 2021 | 33,138.00 |